Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

BofA starts coverage on Ryan Specialty with buy, deems stock undervalued

Published 2024-05-22, 11:30 a/m
RYAN
-

On Wednesday, BofA Securities began coverage on shares of Ryan Specialty Group (NYSE:RYAN), a major wholesale insurance broker, assigning a Buy rating and setting a price target of $67.00.

The firm highlighted Ryan Specialty's position as the second-largest broker in its sector and its performance since its initial public offering in 2021. The company has maintained a premium valuation compared to the broader market and its peers due to its strong organic growth and significant role in the excess & surplus insurance market.

Despite facing valuation pressures earlier in the year due to concerns over a potential slowdown in broker growth and cautious remarks from the Federal Reserve, Ryan Specialty's stock has not fully bounced back. BofA Securities suggests that the company's valuation does not fully reflect its above-average growth prospects.

Ryan Specialty's robust double-digit organic growth profile has been a key factor in its premium market valuation since its IPO. The excess & surplus insurance market, where Ryan Specialty is a leading player, has been rapidly expanding, further cementing the company's strong market position.

BofA Securities' price target of $67.00 indicates confidence in the company's ability to sustain its growth trajectory. The firm's analyst stated, "We think Ryan's above-average underlying growth profile is more sustainable than the current valuation implies."

The initiation of coverage and the optimistic price target by BofA Securities could potentially influence investor sentiment towards Ryan Specialty Group, as the company continues to navigate the competitive insurance brokerage landscape.

InvestingPro Insights

As Ryan Specialty Group (NYSE:RYAN) garners attention with BofA Securities' optimistic outlook, real-time data from InvestingPro underscores the company's financial landscape. With a market capitalization of $14.06 billion, Ryan Specialty is trading at a forward P/E ratio of 68.8, which indicates a high earnings multiple compared to the industry average. This valuation is further reflected in its Price/Book ratio of 25.36, suggesting that investors are willing to pay a premium for the company's book value.

The company's financial health is also evidenced by its revenue growth, with a notable 19.42% increase over the last twelve months as of Q1 2024. Moreover, Ryan Specialty has demonstrated a strong return over the last three months, with a price total return of 16.65%. This aligns with the positive sentiment expressed by BofA Securities and reinforces the company's robust performance in the market.

For investors seeking deeper insights, there are additional InvestingPro Tips available for Ryan Specialty. These tips include expectations of net income growth this year and predictions by analysts that the company will be profitable this year, which may provide further confidence to investors considering the stock. To explore these insights and more, investors can use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at https://www.investing.com/pro/RYAN. In total, there are 6 InvestingPro Tips available for Ryan Specialty, offering a comprehensive analysis for informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.